|
|
|
|
Advances in Knowledge Management Support Systems in R&D
Pre-Conference Workshop
chaired by John Conway (Accelrys) and Frank Hollinger (FRESH Directions Consulting)
Bryn Mawr College, Philadelphia, 09.00 -18.00, 13 October 2008 |
The Push and Pull of Knowledge Management in R&D
Knowledge Management in the pharmaceutical industry has been undergoing a transition over the past 5-10 years. With recent changes occurring in the pharmaceutical industry, shifts in the research focus at both large pharmaceuticals and small-mid size pharmaceuticals/ biotechs are becoming more common. The way we view the information food chain has had to change. We are in a world where we need to have greater flexibility and easier access to data than ever before. We are typically working with external as well as internal collaborators on our project teams.
Our objective in this workshop it to discuss how Knowledge Management Systems are being developed in this new age, how they are being used and what changes we as a community should be pushing for in the next generation of systems. We will have a balanced user and developer perspective at the meeting to have a productive dialog. Keeping an eye toward doing things ‘right’ yet while remaining cost conscious, we are often presented with a challenge to put the ‘best’ system in place. Participants will discuss ways forward in solving this problem within organizations, collaborations and discovery teams.
Speaker Presentations and User Perspectives will be used to seed discussions on current and future research needs in Knowledge Management in R&D support systems, which will be carried out using a wiki-supported Knowledge Cafe format.
Presenters & Discussion Leaders
Frank Brown (Accelrys), Data is only valuable if you can extract the information
Chris Culberson (Merck Research Laboratories), Title TBA
Barry Hardy (Douglas Connect), Knowledge-Oriented Collaboration in Virtual Organisation Structures
Tim McIntyre (GlaxoSmithKline), Workflow Application Enhances Productivity
Ralph T. Mosley (Pharmasset), Going Big to Small: What happens when you leave Big Pharma?
Chris Smith (Pfizer), Title TBA
The workshop program continues related workshop activities and discussions carried out at last year’s KM in R&D workshop at Bryn Mawr.
Take a closer look at the workshop program from 2007 which we will be further developing at the 2008 workshop.... |
|
|
|
|
|
|
|
|
|
|
|
